131 related articles for article (PubMed ID: 11177322)
1. Indinavir, zidovudine, lamivudine: 3-year follow-up.
Dworkin MS; Wan PT
Ann Intern Med; 2001 Jan; 134(2):165. PubMed ID: 11177322
[No Abstract] [Full Text] [Related]
2. 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
Gulick RM; Mellors JW; Havlir D; Eron JJ; Meibohm A; Condra JH; Valentine FT; McMahon D; Gonzalez C; Jonas L; Emini EA; Chodakewitz JA; Isaacs R; Richman DD
Ann Intern Med; 2000 Jul; 133(1):35-9. PubMed ID: 10877738
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
[TBL] [Abstract][Full Text] [Related]
4. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
5. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
[TBL] [Abstract][Full Text] [Related]
6. Indinavir nephrolithiasis in warm climates.
Bach MC; Godofsky EW
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):296-7. PubMed ID: 9117466
[No Abstract] [Full Text] [Related]
7. Anti-HIV agents. Indinavir--3 years and still going strong.
TreatmentUpdate; 2000 Sep; 12(6):3-4. PubMed ID: 12132460
[No Abstract] [Full Text] [Related]
8. Drug shows potency against HIV.
Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
[No Abstract] [Full Text] [Related]
9. Antiretroviral rounds. When success is a pain.
Bartlett JG; del Rio C
AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
[No Abstract] [Full Text] [Related]
10. HIV trial stopped early after good results.
Boulton A
BMJ; 1997 Mar; 314(7082):699. PubMed ID: 9116542
[No Abstract] [Full Text] [Related]
11. Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.
Hirsch MS; Steigbigel RT; Staszewski S; McMahon D; Fischl MA; Hirschel B; Squires K; DiNubile MJ; Harvey CM; Chen J; Leavitt RY;
Clin Infect Dis; 2003 Oct; 37(8):1119-24. PubMed ID: 14523778
[TBL] [Abstract][Full Text] [Related]
12. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.
Gulick RM; Mellors JW; Havlir D; Eron JJ; Gonzalez C; McMahon D; Richman DD; Valentine FT; Jonas L; Meibohm A; Emini EA; Chodakewitz JA
N Engl J Med; 1997 Sep; 337(11):734-9. PubMed ID: 9287228
[TBL] [Abstract][Full Text] [Related]
13. Double protease inhibitor regimens with amprenavir show promise.
AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
[No Abstract] [Full Text] [Related]
14. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
[No Abstract] [Full Text] [Related]
15. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
[TBL] [Abstract][Full Text] [Related]
16. Crystalluria and urinary tract abnormalities associated with indinavir.
Clayman RV
J Urol; 1998 Aug; 160(2):633. PubMed ID: 9679944
[No Abstract] [Full Text] [Related]
17. Indirect hyperbilirubinemia with indinavir.
Satija P; Parikh F; Aggarwal V; Sharma B; Hakim A; Pai-Dhungat JV
J Assoc Physicians India; 2002 Oct; 50():1316-7. PubMed ID: 12568221
[TBL] [Abstract][Full Text] [Related]
18. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
Mueller BU; Sleasman J; Nelson RP; Smith S; Deutsch PJ; Ju W; Steinberg SM; Balis FM; Jarosinski PF; Brouwers P; Mistry G; Winchell G; Zwerski S; Sei S; Wood LV; Zeichner S; Pizzo PA
Pediatrics; 1998 Jul; 102(1 Pt 1):101-9. PubMed ID: 9651421
[TBL] [Abstract][Full Text] [Related]
20. Indinavir urinary stones as origin of upper urinary tract obstruction.
John H; Müller NJ; Opravil M; Hauri D
Urol Int; 1997; 59(4):257-9. PubMed ID: 9444746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
